Immutep Stock Based Compensation vs End Period Cash Flow Analysis
IMMP Stock | USD 2.24 0.12 5.08% |
Immutep financial indicator trend analysis is infinitely more than just investigating Immutep Ltd ADR recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immutep Ltd ADR is a good investment. Please check the relationship between Immutep Stock Based Compensation and its End Period Cash Flow accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
Stock Based Compensation vs End Period Cash Flow
Stock Based Compensation vs End Period Cash Flow Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immutep Ltd ADR Stock Based Compensation account and End Period Cash Flow. At this time, the significance of the direction appears to have weak contrarian relationship.
The correlation between Immutep's Stock Based Compensation and End Period Cash Flow is -0.11. Overlapping area represents the amount of variation of Stock Based Compensation that can explain the historical movement of End Period Cash Flow in the same time period over historical financial statements of Immutep Ltd ADR, assuming nothing else is changed. The correlation between historical values of Immutep's Stock Based Compensation and End Period Cash Flow is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Stock Based Compensation of Immutep Ltd ADR are associated (or correlated) with its End Period Cash Flow. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when End Period Cash Flow has no effect on the direction of Stock Based Compensation i.e., Immutep's Stock Based Compensation and End Period Cash Flow go up and down completely randomly.
Correlation Coefficient | -0.11 |
Relationship Direction | Negative |
Relationship Strength | Insignificant |
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.End Period Cash Flow
Most indicators from Immutep's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immutep Ltd ADR current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immutep Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, Immutep's Selling General Administrative is relatively stable compared to the past year. As of 12/13/2024, Issuance Of Capital Stock is likely to grow to about 96.7 M, while Enterprise Value Over EBITDA is likely to drop (2.98).
2021 | 2023 | 2024 (projected) | Reconciled Depreciation | 3.0M | 3.4M | 2.3M | Net Interest Income | 192.0K | 1.1M | 1.1M |
Immutep fundamental ratios Correlations
Click cells to compare fundamentals
Immutep Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Immutep fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 46.6M | 82.0M | 102.2M | 147.4M | 201.6M | 211.7M | |
Other Current Liab | 1.6M | 3.1M | 35.6M | 4.1M | 6.5M | 4.1M | |
Total Current Liabilities | 3.4M | 5.3M | 6.4M | 9.8M | 10.5M | 11.0M | |
Total Stockholder Equity | 33.3M | 73.3M | 94.1M | 136.5M | 189.5M | 199.0M | |
Property Plant And Equipment Net | 250.6K | 309.7K | 308.1K | 468.5K | 679.7K | 713.7K | |
Net Debt | (17.3M) | (57.3M) | (78.3M) | (122.2M) | (160.2M) | (152.2M) | |
Retained Earnings | (275.7M) | (274.6M) | (302.3M) | (339.9M) | (382.6M) | (363.5M) | |
Accounts Payable | 1.6M | 1.8M | 2.9M | 5.4M | 3.8M | 2.3M | |
Cash | 26.3M | 60.1M | 80.0M | 123.4M | 161.8M | 169.9M | |
Non Current Assets Total | 15.4M | 13.6M | 11.4M | 12.5M | 10.2M | 11.0M | |
Cash And Short Term Investments | 26.3M | 60.1M | 80.0M | 123.4M | 181.9M | 191.0M | |
Net Receivables | 3.4M | 6.1M | 8.4M | 8.0M | 7.6M | 7.9M | |
Common Stock Shares Outstanding | 407.3M | 604.3M | 862.3M | 900.6M | 1.2B | 1.3B | |
Liabilities And Stockholders Equity | 46.6M | 82.0M | 102.2M | 147.4M | 201.6M | 211.7M | |
Other Current Assets | 1.4M | 7.8M | 2.4M | 3.6M | 1.9M | 1.7M | |
Other Stockholder Equity | 33.3M | 73.3M | 38.7M | 39.8M | 1.0 | 0.95 | |
Total Liab | 13.3M | 8.8M | 8.1M | 11.0M | 12.1M | 7.8M | |
Property Plant And Equipment Gross | 250.6K | 309.7K | 941.1K | 1.1M | 1.3M | 1.3M | |
Total Current Assets | 31.2M | 68.4M | 90.8M | 135.0M | 191.4M | 200.9M | |
Accumulated Other Comprehensive Income | 66.0M | 34.5M | 29.0M | 30.1M | 30.1M | 29.2M | |
Intangible Assets | 15.1M | 12.7M | 10.4M | 9.4M | 8.1M | 10.1M | |
Short Long Term Debt Total | 9.1M | 2.8M | 1.7M | 1.2M | 1.6M | 1.5M | |
Short Term Debt | 129.4K | 416.4K | 173.4K | 185.2K | 233.6K | 239.1K | |
Non Currrent Assets Other | (15.4M) | 454.2K | 495.7K | 2.5M | 1.3M | 1.4M | |
Non Current Liabilities Total | 9.9M | 3.4M | 1.7M | 1.2M | 1.6M | 1.5M | |
Other Liab | 1.0M | 811.9K | 117.3K | 164.4K | 189.1K | 179.6K | |
Common Stock | 243.0M | 313.4M | 367.4M | 446.3M | 542.1M | 272.8M | |
Property Plant Equipment | 250.6K | 309.7K | 308.1K | 468.5K | 421.7K | 227.9K | |
Common Stock Total Equity | 213.2M | 221.1M | 233.3M | 313.4M | 360.4M | 225.2M | |
Net Tangible Assets | 18.1M | 60.4M | 83.5M | 127.0M | 146.0M | 153.3M | |
Long Term Debt | 8.8M | 2.5M | 2.1M | 835.4K | 751.9K | 714.3K | |
Capital Lease Obligations | 262.4K | 288.3K | 408.3K | 392.8K | 451.7K | 474.3K | |
Net Invested Capital | 42.1M | 75.8M | 138.9M | 137.3M | 157.9M | 165.8M | |
Net Working Capital | 27.8M | 63.1M | 122.7M | 125.2M | 144.0M | 151.2M | |
Capital Stock | 243.0M | 313.4M | 534.1M | 446.3M | 513.2M | 386.7M |
Pair Trading with Immutep
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Immutep position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Immutep will appreciate offsetting losses from the drop in the long position's value.Moving against Immutep Stock
0.57 | BMY | Bristol Myers Squibb | PairCorr |
0.57 | GILD | Gilead Sciences | PairCorr |
0.43 | GNFT | Genfit | PairCorr |
0.34 | FLGC | Flora Growth Corp Buyout Trend | PairCorr |
The ability to find closely correlated positions to Immutep could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Immutep when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Immutep - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Immutep Ltd ADR to buy it.
The correlation of Immutep is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Immutep moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Immutep Ltd ADR moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Immutep can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.